ASCO25: J&J’s trispecific antibody shows 100% response ...
First-in-human data for the trispecific antibody “suggest a paradigm shift” for ...
EC approves Takeda ADC plus chemo for stage IIb Hodgkin...
The European Commission (EC) has granted approval for Takeda's antibody-drug con...
Roche extends SMA market lead with Evrysdi tablet appro...
Already offering the only non-invasive treatment for SMA in liquid form, Roche’s...